Bendeka and Infusion site irritation - a phase IV clinical study of FDA data

Summary:

Infusion site irritation is reported as a side effect among people who take Bendeka (bendamustine hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Benadryl, and have Burkitt lymphoma.

The phase IV clinical study analyzes which people have Infusion site irritation when taking Bendeka. It is created by eHealthMe based on reports of 588 people who have side effects when taking Bendeka from the FDA, and is updated regularly.

What is Bendeka?

Bendeka has active ingredients of bendamustine hydrochloride. eHealthMe is studying from 591 Bendeka users. Check the latest studies of Bendeka.

What is Infusion site irritation?

Infusion site irritation is found to be associated with 143 drugs and 113 conditions by eHealthMe. Check the latest studies of Infusion site irritation.

On Jul, 13, 2026

588 people reported to have side effects when taking Bendeka.
Among them, 27 people (4.59%) have Infusion site irritation.

Could Bendeka cause Infusion site irritation?

Among these 27 people:

How long have people been on Bendeka when they have Infusion site irritation? *

What is the gender of people who have Infusion site irritation when taking Bendeka? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Infusion site irritation when taking Bendeka? *

What are other drugs people take besides Bendeka? *

What are other side effects people have besides Infusion site irritation? *

Infusion Site Reaction: 12 people, 44.44%
Infusion Site Pain: 9 people, 33.33%
Infusion Related Reaction: 3 people, 11.11%
Infusion Site Extravasation (flow of (blood or lymph) from infusion site): 2 people, 7.41%
Infusion Site Discomfort: 2 people, 7.41%
Burning Sensation: 2 people, 7.41%
Mucosal Inflammation (infection of mucous membrane): 1 person, 3.70%
Infusion Site Swelling: 1 person, 3.70%
Infusion Site Erythema (reddening of the skin at infusion site): 1 person, 3.70%
Cellulitis (infection under the skin): 1 person, 3.70%

What are the existing conditions these people have? *

Lymphoma (cancer that begins in immune system cells): 2 people, 7.41%
Burkitt Lymphoma (cancer of the lymphatic system): 2 people, 7.41%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 3.70%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Bendeka and have Infusion site irritation?

- Check whether Infusion site irritation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bendeka:

Bendeka (591 reports)

Browse all side effects of Bendeka:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infusion site irritation:

Infusion site irritation (143 drugs)

Browse all the conditions that are associated with Infusion site irritation:

Infusion site irritation (113 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bendamustine hydrochloride (the active ingredients of Bendeka) and Bendeka (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.